US Stock MarketDetailed Quotes

LCTX Lineage Cell Therapeutics

Watchlist
  • 0.980
  • -0.070-6.67%
Close May 28 16:00 ET
  • 1.010
  • +0.030+3.05%
Post 18:41 ET
185.05MMarket Cap-7538P/E (TTM)

Lineage Cell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-39.48%1.44M
-39.16%8.95M
9.03%2.09M
-58.44%1.25M
-29.17%3.23M
-54.44%2.39M
277.39%14.7M
99.48%1.92M
36.15%3M
932.43%4.55M
Operating revenue
-39.48%1.44M
-39.16%8.95M
9.03%2.09M
-58.44%1.25M
-29.17%3.23M
-54.44%2.39M
277.39%14.7M
99.48%1.92M
36.15%3M
932.43%4.55M
Cost of revenue
-17.65%98K
-7.83%671K
150.98%256K
-28.09%169K
-40.93%127K
-32.39%119K
-48.95%728K
-50.00%102K
-76.14%235K
72.00%215K
Gross profit
-40.63%1.35M
-40.79%8.27M
1.05%1.83M
-61.02%1.08M
-28.58%3.1M
-55.21%2.27M
465.79%13.98M
139.81%1.81M
127.03%2.76M
1,272.78%4.34M
Operating expense
-10.12%8.01M
-9.56%33.01M
-3.05%8.19M
-2.89%7.78M
-5.25%8.12M
-22.24%8.91M
-29.38%36.5M
-70.85%8.45M
-0.57%8.01M
15.90%8.57M
Selling and administrative expenses
5.78%5M
-23.13%17.3M
-1.38%4.29M
-8.62%4.04M
-19.37%4.25M
-44.22%4.72M
23.59%22.51M
-1.72%4.35M
-16.83%4.42M
16.18%5.27M
-General and administrative expense
5.78%5M
-23.13%17.3M
-1.38%4.29M
-8.62%4.04M
-19.37%4.25M
-44.22%4.72M
23.59%22.51M
-1.72%4.35M
-16.83%4.42M
16.18%5.27M
Research and development costs
-28.08%3.01M
12.28%15.71M
-4.82%3.91M
4.15%3.74M
17.29%3.87M
40.06%4.19M
-58.76%13.99M
-83.44%4.1M
27.78%3.59M
12.66%3.3M
Operating profit
-0.29%-6.66M
-9.83%-24.73M
4.17%-6.36M
-27.69%-6.71M
-18.66%-5.02M
-3.85%-6.64M
54.24%-22.52M
76.49%-6.64M
23.26%-5.25M
40.20%-4.23M
Net non-operating interest income expense
12.68%462K
96.50%1.63M
2.54%404K
12.76%433K
649.02%382K
40,900.00%410K
41,350.00%829K
13,033.33%394K
38,300.00%384K
1,800.00%51K
Non-operating interest income
12.68%462K
96.50%1.63M
2.54%404K
12.76%433K
649.02%382K
40,900.00%410K
41,350.00%829K
--394K
--384K
--51K
Other net income (expense)
-1,536.00%-359K
95.68%-178K
1,163.25%1.24M
-25.14%-886K
78.41%-561K
103.58%25K
-169.39%-4.12M
-151.77%-117K
64.67%-708K
-222.71%-2.6M
Gain on sale of security
16.90%-359K
91.16%-174K
99.03%-5K
74.25%-60K
78.78%-150K
15.95%-432K
-150.10%-1.97M
67.36%-515K
90.28%-233K
-213.12%-707K
Other non- operating income (expenses)
----
99.81%-4K
213.82%1.25M
-73.89%-826K
78.28%-411K
348.37%457K
-244.82%-2.15M
-77.94%398K
-220.87%-475K
-295.05%-1.89M
Income before tax
-5.65%-6.56M
9.80%-23.28M
25.90%-4.71M
-28.39%-7.16M
23.28%-5.2M
12.49%-6.21M
40.35%-25.81M
77.29%-6.36M
36.98%-5.58M
-36.60%-6.78M
Income tax
0
-433.27%-1.8M
0
0
0
-1.8M
541K
0
153.46%541K
0
Net income
-48.91%-6.56M
18.50%-21.48M
25.90%-4.71M
-17.04%-7.16M
23.28%-5.2M
37.91%-4.4M
39.10%-26.35M
78.20%-6.36M
21.93%-6.12M
-41.41%-6.78M
Net income continuous Operations
-48.91%-6.56M
18.50%-21.48M
25.90%-4.71M
-17.04%-7.16M
23.28%-5.2M
37.91%-4.4M
39.10%-26.35M
78.20%-6.36M
21.93%-6.12M
-41.41%-6.78M
Minority interest income
50.00%-16K
108.75%7K
862.50%61K
-2.13%-48K
236.84%26K
-433.33%-32K
68.13%-80K
96.00%-8K
-327.27%-47K
-137.50%-19K
Net income attributable to the parent company
-49.63%-6.54M
18.22%-21.49M
24.85%-4.78M
-17.15%-7.11M
22.68%-5.23M
38.31%-4.37M
38.93%-26.27M
78.08%-6.35M
22.42%-6.07M
-41.25%-6.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-49.63%-6.54M
18.22%-21.49M
24.85%-4.78M
-17.15%-7.11M
22.68%-5.23M
38.31%-4.37M
38.93%-26.27M
78.08%-6.35M
22.42%-6.07M
-41.25%-6.76M
Basic earnings per share
-33.33%-0.04
20.00%-0.12
33.33%-0.02
0.00%-0.04
25.00%-0.03
25.00%-0.03
42.31%-0.15
82.35%-0.03
20.00%-0.04
-33.33%-0.04
Diluted earnings per share
-33.33%-0.04
20.00%-0.12
33.33%-0.02
0.00%-0.04
25.00%-0.03
25.00%-0.03
42.31%-0.15
82.35%-0.03
20.00%-0.04
-33.33%-0.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -39.48%1.44M-39.16%8.95M9.03%2.09M-58.44%1.25M-29.17%3.23M-54.44%2.39M277.39%14.7M99.48%1.92M36.15%3M932.43%4.55M
Operating revenue -39.48%1.44M-39.16%8.95M9.03%2.09M-58.44%1.25M-29.17%3.23M-54.44%2.39M277.39%14.7M99.48%1.92M36.15%3M932.43%4.55M
Cost of revenue -17.65%98K-7.83%671K150.98%256K-28.09%169K-40.93%127K-32.39%119K-48.95%728K-50.00%102K-76.14%235K72.00%215K
Gross profit -40.63%1.35M-40.79%8.27M1.05%1.83M-61.02%1.08M-28.58%3.1M-55.21%2.27M465.79%13.98M139.81%1.81M127.03%2.76M1,272.78%4.34M
Operating expense -10.12%8.01M-9.56%33.01M-3.05%8.19M-2.89%7.78M-5.25%8.12M-22.24%8.91M-29.38%36.5M-70.85%8.45M-0.57%8.01M15.90%8.57M
Selling and administrative expenses 5.78%5M-23.13%17.3M-1.38%4.29M-8.62%4.04M-19.37%4.25M-44.22%4.72M23.59%22.51M-1.72%4.35M-16.83%4.42M16.18%5.27M
-General and administrative expense 5.78%5M-23.13%17.3M-1.38%4.29M-8.62%4.04M-19.37%4.25M-44.22%4.72M23.59%22.51M-1.72%4.35M-16.83%4.42M16.18%5.27M
Research and development costs -28.08%3.01M12.28%15.71M-4.82%3.91M4.15%3.74M17.29%3.87M40.06%4.19M-58.76%13.99M-83.44%4.1M27.78%3.59M12.66%3.3M
Operating profit -0.29%-6.66M-9.83%-24.73M4.17%-6.36M-27.69%-6.71M-18.66%-5.02M-3.85%-6.64M54.24%-22.52M76.49%-6.64M23.26%-5.25M40.20%-4.23M
Net non-operating interest income expense 12.68%462K96.50%1.63M2.54%404K12.76%433K649.02%382K40,900.00%410K41,350.00%829K13,033.33%394K38,300.00%384K1,800.00%51K
Non-operating interest income 12.68%462K96.50%1.63M2.54%404K12.76%433K649.02%382K40,900.00%410K41,350.00%829K--394K--384K--51K
Other net income (expense) -1,536.00%-359K95.68%-178K1,163.25%1.24M-25.14%-886K78.41%-561K103.58%25K-169.39%-4.12M-151.77%-117K64.67%-708K-222.71%-2.6M
Gain on sale of security 16.90%-359K91.16%-174K99.03%-5K74.25%-60K78.78%-150K15.95%-432K-150.10%-1.97M67.36%-515K90.28%-233K-213.12%-707K
Other non- operating income (expenses) ----99.81%-4K213.82%1.25M-73.89%-826K78.28%-411K348.37%457K-244.82%-2.15M-77.94%398K-220.87%-475K-295.05%-1.89M
Income before tax -5.65%-6.56M9.80%-23.28M25.90%-4.71M-28.39%-7.16M23.28%-5.2M12.49%-6.21M40.35%-25.81M77.29%-6.36M36.98%-5.58M-36.60%-6.78M
Income tax 0-433.27%-1.8M000-1.8M541K0153.46%541K0
Net income -48.91%-6.56M18.50%-21.48M25.90%-4.71M-17.04%-7.16M23.28%-5.2M37.91%-4.4M39.10%-26.35M78.20%-6.36M21.93%-6.12M-41.41%-6.78M
Net income continuous Operations -48.91%-6.56M18.50%-21.48M25.90%-4.71M-17.04%-7.16M23.28%-5.2M37.91%-4.4M39.10%-26.35M78.20%-6.36M21.93%-6.12M-41.41%-6.78M
Minority interest income 50.00%-16K108.75%7K862.50%61K-2.13%-48K236.84%26K-433.33%-32K68.13%-80K96.00%-8K-327.27%-47K-137.50%-19K
Net income attributable to the parent company -49.63%-6.54M18.22%-21.49M24.85%-4.78M-17.15%-7.11M22.68%-5.23M38.31%-4.37M38.93%-26.27M78.08%-6.35M22.42%-6.07M-41.25%-6.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -49.63%-6.54M18.22%-21.49M24.85%-4.78M-17.15%-7.11M22.68%-5.23M38.31%-4.37M38.93%-26.27M78.08%-6.35M22.42%-6.07M-41.25%-6.76M
Basic earnings per share -33.33%-0.0420.00%-0.1233.33%-0.020.00%-0.0425.00%-0.0325.00%-0.0342.31%-0.1582.35%-0.0320.00%-0.04-33.33%-0.04
Diluted earnings per share -33.33%-0.0420.00%-0.1233.33%-0.020.00%-0.0425.00%-0.0325.00%-0.0342.31%-0.1582.35%-0.0320.00%-0.04-33.33%-0.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg